BioCentury
ARTICLE | Clinical News

CPC-111 small molecule facilitator of anaerobic glycolysis: Began Phase II trial in the U.K. to measure post-operative myocardial performance of heart bypass pa

February 27, 1995 8:00 AM UTC

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-111 small molecule facilitator of anaerobic glycolysis Indication: Cardioplegia (stopping the heart during surgery) Status: Began Phas...